Nephrology

Doç. Dr. Meral Meşe

Doctor and researcher Kartal Dr. Lütfi Kırdar Şehir Hastanesi İstanbul
Diabetic NephropathiesFabry Disease
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Diabetic Nephropathies 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Fabry Disease 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNephrologysaglik.gov.trFrom source
  • InstitutionKartal Dr. Lütfi Kırdar Şehir Hastanesisaglik.gov.trFrom source
  • Area of workDiabetic NephropathiesExtracted from 2 publications · Model version —From source
  • Publications43 publicationsOpenAlexFrom source
  • ORCID0000-0002-6104-2058ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://lutfikirdareah.saglik.gov.tr/TR-1480114/doktorlarimiz.html#meral-mesesaglik.gov.tr

Scientific work

Publications on Diabetic Nephropathies

43 publications

  1. Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry

    Cardiovascular Drugs and Therapy, 2026

    DOI 10.1007/s10557-026-07944-w PMID 42720721 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  2. Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort

    Clinical Kidney Journal, 2026

    DOI 10.1093/ckj/sfag227 PMID 42592375 Open-access full textSource: OpenAlex

  3. Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15155758 PMID 42589862 Open-access full textSource: OpenAlex

  4. Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study

    BMC Nephrology, 2026

    DOI 10.1186/s12882-026-05259-4 PMID 42693414 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  5. Morphometric analysis of retroperitoneal organs in individuals with unilateral congenital renal agenesis and renal hypoplasia

    Pakistan Journal of Medical Sciences, 2026

    DOI 10.12669/pjms.42.1.13016 PMID 41737159 Open-access full textSource: OpenAlex

  6. Serratia marcescens peritonitis in a continuous ambulatory peritoneal dialysis patient: A case report and literature review

    IDCases, 2026

    DOI 10.1016/j.idcr.2026.e02764 PMID 42824569 Open-access full textSource: OpenAlex

  7. Pregnancy associated plasma protein-A: a promising biomarker in kidney diseases

    Turkish Journal of Biochemistry, 2025

    DOI 10.1515/tjb-2024-0241 Open-access full textSource: OpenAlex

  8. Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis

    PLoS ONE, 2024

    DOI 10.1371/journal.pone.0312470 PMID 39471136 13 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. Investigation of COVID-19 Vaccine Acceptance and Early Side Effects of COVID-19 Vaccine in Hemodialysis Patients

    Turkish Journal of Nephrology, 2023

    DOI 10.5152/turkjnephrol.2023.2234305 Open-access full textSource: OpenAlex

  10. Six months follow up of hemodialysis patients after SARS-CoV-2 vaccinations: Effects of the booster dose and vaccine t

    Dicle Medical Journal / Dicle Tip Dergisi, 2023

    DOI 10.5798/dicletip.1313206 Open-access full textSource: OpenAlex

View all 43 publications